GNMSF vs AMGN: Which Stock is Better?
Side-by-side comparison of Genmab A/S and Amgen Inc in 2026
GNMSF
Genmab A/S
—
AMGN
Amgen Inc
$364.17
Key Metrics Comparison
| Metric | GNMSF | AMGN | Winner |
|---|---|---|---|
| Market Cap | $14.85B | $188.67B | AMGN |
| P/E Ratio | 18.39 | 24.33 | GNMSF |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze GNMSF
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GNMSF or AMGN a better investment?
Comparing GNMSF and AMGN: Genmab A/S has a market cap of $14.85B while Amgen Inc has $188.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GNMSF and AMGN?
GNMSF (Genmab A/S) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GNMSF or AMGN?
Based on P/E ratios, GNMSF trades at a lower multiple (18.4x vs 24.3x).
Which is growing faster: GNMSF or AMGN?
Both GNMSF and AMGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: GNMSF or AMGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: GNMSF or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.67B compared to $14.85B for GNMSF.
Should I buy GNMSF or AMGN in 2026?
Both GNMSF and AMGN have investment merit. GNMSF trades at $N/A while AMGN trades at $364.17. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GNMSF and AMGN stock?
Key differences: Market Cap ($14.85B vs $188.67B), P/E Ratio (18.4x vs 24.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy GNMSF or AMGN in 2026?
The choice between GNMSF and AMGN depends on your investment goals. AMGN shows higher revenue growth (0.0%). AMGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GNMSF and AMGN?
GNMSF (Genmab A/S) has a market cap of $14.85B, while AMGN (Amgen Inc) has a market cap of $188.67B. AMGN is the larger company by market value.